![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » FDA Approves Biotronik’s Tiny Quadripolar Cardiac Resynchronization Therapy Pacemaker
FDA Approves Biotronik’s Tiny Quadripolar Cardiac Resynchronization Therapy Pacemaker
![heart-on-yellow.gif](https://www.fdanews.com/ext/resources/test/Device_Images/heart-on-yellow.gif?t=1577068037&width=430)
August 25, 2017
Biotronik secured FDA approval for its Edora HF-T QP MR conditional quadripolar cardiac resynchronization therapy pacemaker (CRT-P).
The device allows physicians to tell the implant an MRI exam is coming up, so the device can to automatically engage its MRI safety mode during a scan.
The device has a total volume of only 15 cc, making it the smallest MR-conditional CRT-P on the U.S. market.
Upcoming Events
-
21Oct